Publication | Open Access

Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified

Metastatic Breast CancerOncologyBreast OncologyMedicineCancer ManagementLiposomal DoxorubicinBreast CancerFirst-line MonotherapyCancer TreatmentPharmacologyRadiation Oncology